Hepatic lipase activity is increased in insulin resistant states and this is associated with reduced HDL cholesterol levels
However, neither directly addresses nausea and should not be used routinely without specific indication
However, these standard treatments have important limitations and unmet clinical needs
EBioMedicine , 12 , 32-33 Cancelas, Jose A
The battle of the GLP-1 agonists Glucagon-like peptide 1 (GLP-1) agonists, which can be used to treat Type 2 diabetes and for weight management, are a rising class of blockbuster drugs (defined as drugs with sales of $1 billion or more)
On the other hand, Eastern medicine focuses more on holistic healing by addressing the root cause rather than the symptom